五年亏超30亿元,艾美疫苗仍在失血

北京商报
Aug 24

五年累计亏损超30亿元后,艾美疫苗仍未止血。8月23日晚间,艾美疫苗发布2026年中期业绩,上半年实现收入3.51亿元,同比下降31.87%;净亏损1.23亿元,较上年同期的1.31亿元有些许收窄。不过,减亏并非来自经营改善,而是研发及销售开支的大幅缩减。  拉长时间线来看,艾美疫苗自2021年起便持续亏损。2021年至2025年,艾美疫苗归母净亏损分别为6.93亿元、3.2亿元、13.01亿元、...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10